Abstract
Ovarian hyperstimulation syndrome (OHSS) is the most serious iatrogenic complication associated with ovarian stimulation. It is only in recent years that the understanding of OHSS has advanced sufficiently to develop treatment options aimed at reducing the incidence and effects of OHSS. Currently, there is no good test or method for identifying susceptible patients. Nevertheless, progress has been made in the prevention of OHSS. Physicians have a wide range of treatment options, including coasting, re-initiation of a GnRH antagonist, and application of agonists, like dopamine in the luteal phase or triggering oocyte maturation with a bolus of GnRH agonist. These treatments, together with other procedures, like oocyte/embryo vitrification, have allowed physicians to improve the prediction and prevention of OHSS.
Keywords: Agonist triggering, ART, hCG, OHSS, prevention.
Current Drug Targets
Title:GnRH-Agonist Triggering to Avoid Ovarian Hyperstimulation Syndrome: A Review of the Evidence
Volume: 14 Issue: 8
Author(s): Maria Cerrillo Martinez, Francisco J. Ruiz and Juan A. García-Velasco
Affiliation:
Keywords: Agonist triggering, ART, hCG, OHSS, prevention.
Abstract: Ovarian hyperstimulation syndrome (OHSS) is the most serious iatrogenic complication associated with ovarian stimulation. It is only in recent years that the understanding of OHSS has advanced sufficiently to develop treatment options aimed at reducing the incidence and effects of OHSS. Currently, there is no good test or method for identifying susceptible patients. Nevertheless, progress has been made in the prevention of OHSS. Physicians have a wide range of treatment options, including coasting, re-initiation of a GnRH antagonist, and application of agonists, like dopamine in the luteal phase or triggering oocyte maturation with a bolus of GnRH agonist. These treatments, together with other procedures, like oocyte/embryo vitrification, have allowed physicians to improve the prediction and prevention of OHSS.
Export Options
About this article
Cite this article as:
Martinez Cerrillo Maria, Ruiz J. Francisco and García-Velasco A. Juan, GnRH-Agonist Triggering to Avoid Ovarian Hyperstimulation Syndrome: A Review of the Evidence, Current Drug Targets 2013; 14 (8) . https://dx.doi.org/10.2174/13894501113149990163
DOI https://dx.doi.org/10.2174/13894501113149990163 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Call for Papers in Thematic Issues
New drug therapy for eye diseases
Eyesight is one of the most critical senses, accounting for over 80% of our perceptions. Our quality of life might be significantly affected by eye disease, including glaucoma, diabetic retinopathy, dry eye, etc. Although the development of microinvasive ocular surgery reduces surgical complications and improves overall outcomes, medication therapy is ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Cell Therapy for the Treatment of Chronic Ischemic Heart Disease
Current Pharmaceutical Design Acute Myocarditis in Children: An Overview of Treatment and Recent Patents
Recent Patents on Inflammation & Allergy Drug Discovery Systemic Sclerosis: Clinical Manifestations
Current Rheumatology Reviews Targeted Therapies for Advanced Non-Small Cell Lung Cancer
Combinatorial Chemistry & High Throughput Screening Aortic Dissection: A Review of the Pathophysiology, Management and Prospective Advances
Current Cardiology Reviews Heart Failure in Chronic Myocarditis: A Role for microRNAs?
Current Genomics Cardiac Involvement in ANCA (+) and ANCA (-) Churg-Strauss Syndrome Evaluated by Cardiovascular Magnetic Resonance
Inflammation & Allergy - Drug Targets (Discontinued) Pulmonary Hypertension and Lung Transplant in Connective Tissue Disease-Interstitial Lung Disease
Current Respiratory Medicine Reviews Pathophysiology of Myocardial Infarction and Acute Management Strategies
Cardiovascular & Hematological Agents in Medicinal Chemistry Myopericarditis, as the First Sign of Rheumatoid Arthritis Relapse, Evaluated by Cardiac Magnetic Resonance
Inflammation & Allergy - Drug Targets (Discontinued) The Diagnosis of Large Airway Pathology and the Role of Rigid Bronchoscopy
Current Respiratory Medicine Reviews What’s Old is New Again – A Review of the Current Evidence of Colchicine in Cardiovascular Medicine
Current Cardiology Reviews First Comprehensive Analysis of Outcomes in Adult Patients after Percutaneous Closure of Isolated Secundum Atrial Septal Defects
Cardiovascular & Hematological Agents in Medicinal Chemistry Noninvasive Diagnosis of Chemotherapy Related Cardiotoxicity
Current Cardiology Reviews Mesothelioma - Update on Management
Current Respiratory Medicine Reviews Cardiovascular Magnetic Resonance Imaging: State of the Art
Current Cardiology Reviews Biomarkers in Acute Heart Failure Syndromes: An Update
Current Cardiology Reviews Congenital Disorders of Glycosylation (CDG): Update and Perspectives
Current Pediatric Reviews Evaluation of Echocardiographic Abnormalities in HIV Positive Patients Treated with Antiretroviral Medications
Infectious Disorders - Drug Targets Cryoballoon Ablation for the Treatment of Atrial Fibrillation: A Meta-analysis
Current Cardiology Reviews